Split 3rd Circ. Keeps Merck Vaccine Antitrust Panel Immunity

By Bryan Koenig · February 11, 2025, 7:35 PM EST

The full Third Circuit refused to reconsider a ruling that immunized Merck & Co. from antitrust claims over submissions it made to federal regulators for its mumps vaccine, over the objection...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

In re: Merck Mumps Vaccine Antitrust Litigation

Case Number

Court

Appellate - 3rd Circuit

Nature of Suit

3410 Antitrust

Date Filed

November 27, 2023

Recent Articles By Bryan

February 19, 2025
Judge Won't Halt PBM Case Over Attack on FTC Indepenence
February 14, 2025
FTC's Ferguson, PBMs Agree: Nix Leader Removal Safeguards
February 10, 2025
UnitedHealth Says Fed Suit Imperils Deal's Many Benefits
January 30, 2025
DOJ Calls UnitedHealth Dismissal Bid A Discovery 'End Run'
January 10, 2025
Infosys Files Antitrust Counterclaims In Trade Secrets Suit
January 09, 2025
Amgen Says Enbrel Protected By Legit Patents, Rulings
January 03, 2025
DOJ Wants Oct. Amedisys Trial, UnitedHealth Wants Aug.
December 19, 2024
FTC Says PBMs Can't Get Preliminary Block In Insulin Case
December 03, 2024
PE-Backed Anesthesia Giant Can't Duck Antitrust Claims
November 15, 2024
PBMs Denied Breakup Of Combined FTC Insulin Price Trial